CD274 and cancer: Whereas neoadjuvant chemotherapy aims to preoperatively “debulk” tumors to resectable ones, neoadjuvant PD-(L)1 blockades, termed normalization cancer immunotherapy, exploit strategy based on immune evasion mechanisms to restore antitumor immunity to defend tumor antigens.